{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T23:52:42Z","timestamp":1791503562527,"version":"4.3.4"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2022,1,23]],"date-time":"2022-01-23T00:00:00Z","timestamp":1642896000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2022,1,23]],"date-time":"2022-01-23T00:00:00Z","timestamp":1642896000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/100020297","name":"Abiomed","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100020297","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Adv Ther"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1007\/s12325-022-02040-5","type":"journal-article","created":{"date-parts":[[2022,1,23]],"date-time":"2022-01-23T18:02:45Z","timestamp":1642960965000},"page":"1293-1309","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Budget Impact Analysis of Impella CP\u00ae Utilization in the Management of Cardiogenic Shock in France: A Health Economic Analysis"],"prefix":"10.1007","volume":"39","author":[{"given":"Cl\u00e9ment","family":"Delmas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathieu","family":"Pernot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandre","family":"Le Guyader","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Romain","family":"Joret","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"St\u00e9phane","family":"Roze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillaume","family":"Lebreton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,1,23]]},"reference":[{"issue":"2","key":"2040_CR1","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1177\/2048872619894254","volume":"9","author":"U Zeymer","year":"2020","unstructured":"Zeymer U, Bueno H, Granger CB, et al. Acute Cardiovascular Care Association position statement for the diagnosis and treatment of patients with acute myocardial infarction complicated by cardiogenic shock: a document of the Acute Cardiovascular Care Association of the European Society of Cardiology. Eur Heart J Acute Cardiovasc Care. 2020;9(2):183\u201397.","journal-title":"Eur Heart J Acute Cardiovasc Care"},{"key":"2040_CR2","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1002\/ccd.28329","volume":"94","author":"DA Baran","year":"2019","unstructured":"Baran DA, Grines CL, Bailey S, et al. SCAI clinical expert consensus statement on the classification of cardiogenic shock: this document was endorsed by the American College of Cardiology (ACC), the American Heart Association (AHA), the Society of Critical Care Medicine (SCCM), and the Society of Thoracic Surgeons (STS). Catheter Cardiovasc Inter. 2019;94:29\u201337.","journal-title":"Catheter Cardiovasc Inter"},{"issue":"8","key":"2040_CR3","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1002\/ejhf.1922","volume":"22","author":"O Chioncel","year":"2020","unstructured":"Chioncel O, Parissis J, Mebazaa A, et al. Epidemiology, pathophysiology and contemporary management of cardiogenic shock\u2014a position statement from the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail. 2020;22(8):1315\u201341 (Erratum in: Eur J Heart Fail. 2021; 23(2):345).","journal-title":"Eur J Heart Fail"},{"issue":"16","key":"2040_CR4","doi-asserted-by":"crossref","first-page":"e232","DOI":"10.1161\/CIR.0000000000000525","volume":"136","author":"S van Diepen","year":"2017","unstructured":"van Diepen S, Katz JN, Albert NM, et al. (American Heart Association Council on Clinical Cardiology; Council on Cardiovascular and Stroke Nursing; Council on Quality of Care and Outcomes Research; and Mission: Lifeline) Contemporary management of cardiogenic shock: a scientific statement from the American Heart Association. Circulation. 2017;136(16):e232\u201368.","journal-title":"Circulation"},{"issue":"20","key":"2040_CR5","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1093\/eurheartj\/ehv051","volume":"36","author":"H Thiele","year":"2015","unstructured":"Thiele H, Ohman EM, Desch S, Eitel I, de Waha S. Management of cardiogenic shock. Eur Heart J. 2015;36(20):1223\u201330.","journal-title":"Eur Heart J"},{"issue":"4","key":"2040_CR6","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1002\/ejhf.1750","volume":"22","author":"N Aissaoui","year":"2020","unstructured":"Aissaoui N, Puymirat E, Delmas C, et al. Trends in cardiogenic shock complicating acute myocardial infarction. Eur J Heart Fail. 2020;22(4):664\u201372.","journal-title":"Eur J Heart Fail"},{"key":"2040_CR7","unstructured":"Ollivier J, Fresselinat A, Seguy B, et al. The use of Impella 5.0 in refractory cardiogenic shock: a medico-economic report. Pharm J Medical Devices. 2019. https:\/\/www.euro-pharmat.com\/la-revue-du-dm. Accessed 17 Mar 2020."},{"issue":"4","key":"2040_CR8","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1097\/MCC.0000000000000624","volume":"25","author":"S van Diepen","year":"2019","unstructured":"van Diepen S, Thiele H. An overview of international cardiogenic shock guidelines and application in clinical practice. Curr Opin Crit Care. 2019;25(4):365\u201370.","journal-title":"Curr Opin Crit Care"},{"issue":"10","key":"2040_CR9","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1016\/j.acvd.2018.03.008","volume":"111","author":"L Bonello","year":"2018","unstructured":"Bonello L, Delmas C, Schurtz G, et al. Mechanical circulatory support in patients with cardiogenic shock in intensive care units: a position paper of the \u201cUnit\u00e9 de Soins Intensifs de Cardiologie\u201d group of the French Society of Cardiology, endorsed by the \u201cGroupe Ath\u00e9rome et Cardiologie Interventionnelle\u201d of the French Society of Cardiology. Arch Cardiovasc Dis. 2018;111(10):601\u201312.","journal-title":"Arch Cardiovasc Dis"},{"key":"2040_CR10","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1016\/j.jacc.2014.07.958","volume":"64","author":"R Stretch","year":"2014","unstructured":"Stretch R, Sauer CM, Yuh DD, Bonde P. National trends in the utilization of short-term mechanical circulatory support: incidence, outcomes, and cost analysis. J Am Coll Cardiol. 2014;64:1407.","journal-title":"J Am Coll Cardiol"},{"issue":"14","key":"2040_CR11","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1056\/NEJMoa1208410","volume":"367","author":"H Thiele","year":"2012","unstructured":"Thiele H, Zeymer U, Neumann F-J, et al. Intraaortic balloon support for myocardial infarction with cardiogenic shock. N Engl J Med. 2012;367(14):1287\u201396.","journal-title":"N Engl J Med"},{"key":"2040_CR12","first-page":"CD007398","volume":"3","author":"S Unverzagt","year":"2015","unstructured":"Unverzagt S, Buerke M, de Waha A, et al. Intra-aortic balloon pump counterpulsation [IABP] for myocardial infarction complicated by cardiogenic shock. Cochrane Database Syst Rev. 2015;3:CD007398.","journal-title":"Cochrane Database Syst Rev"},{"key":"2040_CR13","unstructured":"Abiomed. Impella CP. 2020. https:\/\/www.abiomed.com\/impella\/impella-cp. Accessed 5 Nov 2020."},{"key":"2040_CR14","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.resuscitation.2016.10.003","volume":"112","author":"H Vasea","year":"2017","unstructured":"Vasea H, Christensen S, Chistiansen A, et al. The Impella CP device for acute mechanical circulatory support in refractory cardiac arrest. Resuscitation. 2017;112:70\u20134.","journal-title":"Resuscitation"},{"issue":"3","key":"2040_CR15","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1016\/j.athoracsur.2016.12.049","volume":"104","author":"S Tepper","year":"2017","unstructured":"Tepper S, Masood MF, Garcia MB, et al. Left ventricular unloading by Impella device versus surgical vent during extracorporeal life support. Ann Thorac Surg. 2017;104(3):861\u20137.","journal-title":"Ann Thorac Surg"},{"key":"2040_CR16","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1016\/j.jacc.2007.10.050","volume":"51","author":"KD Jauw","year":"2008","unstructured":"Jauw KD, Remmelink M, Baan J, et al. Left ventricular unloading in acute ST-segment elevation myocardial infarction patients is safe and feasible and provides acute and sustained left ventricular recovery. J Am Coll Cardiol. 2008;51:1044.","journal-title":"J Am Coll Cardiol"},{"key":"2040_CR17","doi-asserted-by":"publisher","first-page":"2072","DOI":"10.1097\/CCM.0b013e31821e89b5","volume":"39","author":"AE Engstrom","year":"2011","unstructured":"Engstrom AE, Cocchieri R, Driessen AH, et al. The Impella 2.5 and 5.0 devices for ST-elevation myocardial infarction patients presenting with severe and profound cardiogenic shock: the Academic Medical Center intensive care unit experience. Crit Care Med. 2011;39:2072.","journal-title":"Crit Care Med"},{"key":"2040_CR18","doi-asserted-by":"publisher","first-page":"1584","DOI":"10.1016\/j.jacc.2008.05.065","volume":"52","author":"M Seyfarth","year":"2008","unstructured":"Seyfarth M, Sibbing D, Bauer I, et al. A randomized clinical trial to evaluate the safety and efficacy of a percutaneous left ventricular assist device versus intra-aortic balloon pumping for treatment of cardiogenic shock caused by myocardial infarction. J Am Coll Cardiol. 2008;52:1584.","journal-title":"J Am Coll Cardiol"},{"key":"2040_CR19","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1016\/j.ijcard.2015.10.063","volume":"202","author":"DM Ouweneel","year":"2016","unstructured":"Ouweneel DM, Engstrom AE, Sjauw KD, et al. Experience from a randomized controlled trial with Impella 2.5 versus IABP in STEMI patients with cardiogenic pre-shock. Lessons learned from the IMPRESS in STEMI trial. Int J Cardiol. 2016;202:894.","journal-title":"Int J Cardiol"},{"issue":"2","key":"2040_CR20","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1177\/2048872619865891","volume":"9","author":"M Karami","year":"2020","unstructured":"Karami M, den Uil CA, Ouweneel DM, et al. Mechanical circulatory support in cardiogenic shock from acute myocardial infarction: Impella CP\/5.0 versus ECMO. Eur Heart J Acute Cardiovasc Care. 2020;9(2):164\u201372.","journal-title":"Eur Heart J Acute Cardiovasc Care"},{"issue":"3","key":"2040_CR21","first-page":"1","volume":"17","author":"K Chevreul","year":"2015","unstructured":"Chevreul K, Berg Brigham K, Durand-Zaleski I, Hernandez-Quevedo C. France: health system review. Health Syst Transit. 2015;17(3):1\u201321.","journal-title":"Health Syst Transit"},{"issue":"1","key":"2040_CR22","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1093\/ejcts\/ezx088","volume":"52","author":"CA den Uil","year":"2017","unstructured":"den Uil CA, Akin S, Jewbali LS, et al. Short-term mechanical circulatory support as a bridge to durable left ventricular assist device implantation in refractory cardiogenic shock: a systematic review and meta-analysis. Eur J Cardiothorac Surg. 2017;52(1):14\u201325.","journal-title":"Eur J Cardiothorac Surg"},{"issue":"2","key":"2040_CR23","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1016\/j.athoracsur.2013.09.008","volume":"97","author":"R Cheng","year":"2014","unstructured":"Cheng R, Hachamovitch R, Kittleson M, et al. Complications of extracorporeal membrane oxygenation for treatment of cardiogenic shock and cardiac arrest: a meta-analysis of 1,866 adult patients. Ann Thorac Surg. 2014;97(2):610\u20136.","journal-title":"Ann Thorac Surg"},{"key":"2040_CR24","unstructured":"Mejean C. Prise en charge du choc cardiog\u00e9nique \u00e0 la phase aigu\u00eb de l\u2019infarctus du myocarde: Etude r\u00e9trospective, portant sur 50 cas [Management of cardiogenic shock in the acute phase of myocardial infarction: Retrospective study, covering 50 cases]. Sciences du Vivant [q-bio]. 2001. hal-01733636. Available at: https:\/\/hal.univ-lorraine.fr\/hal-01733636\/document Accessed 21 Jan 2022."},{"issue":"4","key":"2040_CR25","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1007\/s40273-017-0602-5","volume":"36","author":"S Ghabri","year":"2018","unstructured":"Ghabri S, Autin E, Poulli\u00e9 AI, Josselin JM. The French National Authority for Health (HAS) guidelines for conducting budget impact analyses (BIA). Pharmacoeconomics. 2018;36(4):407\u201317.","journal-title":"Pharmacoeconomics"},{"issue":"1","key":"2040_CR26","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.jval.2013.08.2291","volume":"17","author":"SD Sullivan","year":"2014","unstructured":"Sullivan SD, Mauskopf JA, Augustovski F, et al. Budget impact analysis-principles of good practice: report of the ISPOR 2012 Budget Impact Analysis Good Practice II Task Force. Value Health. 2014;17(1):5\u201314.","journal-title":"Value Health"},{"key":"2040_CR27","unstructured":"Agence Technique de l\u2019Information sur l\u2019Hospitalisation. Formats PMSI 2016. 2017. https:\/\/www.atih.sante.fr\/formats-pmsi-2016. Accessed 15 Dec 2020."},{"key":"2040_CR28","doi-asserted-by":"publisher","first-page":"97","DOI":"10.3166\/rea-2018-0023","volume":"27","author":"C Delmas","year":"2018","unstructured":"Delmas C, Elbaz M, Bonello L, et al. Place de l\u2019assistance circulatoire dans le choc cardiog\u00e9nique en France en 2018: revue de la litt\u00e9rature et perspectives. M\u00e9d Intensive R\u00e9a. 2018;27:97\u2013113.","journal-title":"M\u00e9d Intensive R\u00e9a"},{"key":"2040_CR29","unstructured":"Agence Technique de l\u2019Information sur l\u2019Hospitalisation. Guide d\u2019utilisation: Valorisation de l\u2019activit\u00e9 2018 par les tariffs 2018 et par les tariffs 2019. https:\/\/www.atih.sante.fr\/sites\/default\/files\/public\/content\/3592\/guide_dutilisation_-_valorisation_de_lactivite_2018_par_les_tarifs_2018_et_tarifs_2019.pdf. Accessed 20 Feb 2020."},{"key":"2040_CR30","unstructured":"Liste des Produits et Prestations Remboursables. https:\/\/www.ameli.fr\/sites\/default\/files\/Documents\/615994\/document\/lpp.pdf. Accessed 18 Mar 2020."},{"key":"2040_CR31","unstructured":"Halimi S, Benhamou PY, Charras H. Le cout du pied diabetique. https:\/\/www.fmc-tourcoing.org\/PROGRAMME_FMC\/DIABETE_10_00\/DIABETEFMI\/cout-pied-3.html. Accessed 6 Nov 2020."},{"key":"2040_CR32","unstructured":"l'Assistance publique \u2013 H\u00f4pitaux de Paris [Public Assistance\u2014Hospital of Paris]. Le dispositif Cardiohelp\u00ae, un appareil ECMO portatif ? [The Cardiohelp\u00ae device, a portable ECMO device?]. 2014. http:\/\/cedit.aphp.fr\/hospital-based-hta-levaluation-de-technologies-de-sante-a-lhopital\/point-sur-le-dispositif-cardiohelp-appareil-ecmo-portatif\/. Accessed 8 Jun 2021."},{"issue":"2","key":"2040_CR33","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1002\/ejhf.646","volume":"19","author":"E Puymirat","year":"2017","unstructured":"Puymirat E, Fagon JY, Aegerter P, et al. (Coll\u00e8ge des Utilisateurs de Bases de donn\u00e9es en R\u00e9animation; CUB-R\u00e9a Group [Intensive Care Database User Group]). Cardiogenic shock in intensive care units: evolution of prevalence, patient profile, management and outcomes, 1997\u20132012. Eur J Heart Fail. 2017;19(2):192\u2013200.","journal-title":"Eur J Heart Fail"},{"issue":"16","key":"2040_CR34","doi-asserted-by":"publisher","first-page":"1972","DOI":"10.1016\/j.jacc.2018.07.074","volume":"72","author":"T Rab","year":"2018","unstructured":"Rab T, Ratanapo S, Kern KB, et al. Cardiac shock care centers: JACC review topic of the week. J Am Coll Cardiol. 2018;72(16):1972\u201380.","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"2040_CR35","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1002\/ccd.27427","volume":"91","author":"MB Basir","year":"2018","unstructured":"Basir MB, Schreiber T, Dixon S, et al. Feasibility of early mechanical circulatory support in acute myocardial infarction complicated by cardiogenic shock: the Detroit cardiogenic shock initiative. Catheter Cardiovasc Interv. 2018;91(3):454\u201361.","journal-title":"Catheter Cardiovasc Interv"},{"issue":"6","key":"2040_CR36","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1002\/ccd.29139","volume":"96","author":"ID Hanson","year":"2020","unstructured":"Hanson ID, Tagami T, Mando R, et al. SCAI shock classification in acute myocardial infarction: insights from the National Cardiogenic Shock Initiative. Catheter Cardiovasc Interv. 2020;96(6):1137\u201342.","journal-title":"Catheter Cardiovasc Interv"},{"issue":"4","key":"2040_CR37","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1177\/0391398817752575","volume":"41","author":"ML Esposito","year":"2018","unstructured":"Esposito ML, Jablonski J, Kras A, Krasney S, Kapur NK. Maximum level of mobility with axillary deployment of the Impella 5.0 is associated with improved survival. Int J Artif Organs. 2018;41(4):236\u20139.","journal-title":"Int J Artif Organs"},{"issue":"4","key":"2040_CR38","doi-asserted-by":"publisher","first-page":"1468","DOI":"10.1016\/j.athoracsur.2007.09.017","volume":"85","author":"T Sassard","year":"2008","unstructured":"Sassard T, Scalabre A, Bonnefoy E, Sanchez I, Farhat F, Jegaden O. The right axillary artery approach for the Impella Recover LP 5.0 microaxial pump. Ann Thorac Surg. 2008;85(4):1468\u201377.","journal-title":"Ann Thorac Surg"},{"key":"2040_CR39","doi-asserted-by":"publisher","first-page":"2428648","DOI":"10.1155\/2018\/2428648","volume":"2018","author":"R El Sibai","year":"2018","unstructured":"El Sibai R, Bachir R, El Sayed M. Outcomes in cardiogenic shock patients with extracorporeal membrane oxygenation use: a Matched Cohort Study in Hospitals across the United States. Biomed Res Int. 2018;2018:2428648.","journal-title":"Biomed Res Int"},{"issue":"12","key":"2040_CR40","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.1016\/j.carrev.2020.05.042","volume":"21","author":"A Lemor","year":"2020","unstructured":"Lemor A, Dehkordi SHH, Basir MB, et al. Impella versus extracorporeal membrane oxygenation for acute myocardial infarction cardiogenic shock. Cardiovasc Revasc Med. 2020;21(12):1465\u201371.","journal-title":"Cardiovasc Revasc Med"},{"key":"2040_CR41","unstructured":"Haute Autorit\u00e9 de Sant\u00e9 (HAS). IMPELLA CP, dispositif d\u2019assistance m\u00e9canique \u00e9lectrique percutan\u00e9e, \u00e0 flux axial, monoventriculaire gauche, de courte dur\u00e9e [IMPELLA CP, percutaneous mechanical electrical assistance device, axial flow, left single-ventricular, short duration]. Commission nationale d'evaluation des dispositifs medicaux et des technologies de sante [National Commission for the Evaluation of Medical Devices and Health Technologies]. 2020. https:\/\/www.has-sante.fr\/upload\/docs\/evamed\/CNEDIMTS-5861_IMPELLA%20CP_11_mars_2020_(5861)_avis.pdf. Accessed 9 Jun 2021."},{"key":"2040_CR42","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.ahj.2019.04.019","volume":"214","author":"NJ Udesen","year":"2019","unstructured":"Udesen NJ, M\u00f8ller JE, Lindholm MG, et al. Rationale and design of DanGer shock: Danish-German cardiogenic shock trial. Am Heart J. 2019;214:60\u20138.","journal-title":"Am Heart J"},{"issue":"4","key":"2040_CR43","doi-asserted-by":"publisher","first-page":"759","DOI":"10.3390\/jcm10040759","volume":"10","author":"G Schurtz","year":"2021","unstructured":"Schurtz G, Rousse N, Saura O, et al. IMPELLA \u00ae or extracorporeal membrane oxygenation for left ventricular dominant refractory cardiogenic shock. J Clin Med. 2021;10(4):759.","journal-title":"J Clin Med"},{"issue":"12","key":"2040_CR44","doi-asserted-by":"publisher","first-page":"4130","DOI":"10.3390\/jcm9124130","volume":"9","author":"J Fagot","year":"2020","unstructured":"Fagot J, Bouisset F, Bonello L, et al. Early evaluation of patients on axial flow pump support for refractory cardiogenic shock is associated with left ventricular recovery. J Clin Med. 2020;9(12):4130.","journal-title":"J Clin Med"},{"issue":"3","key":"2040_CR45","doi-asserted-by":"publisher","first-page":"e005853","DOI":"10.1161\/CIRCHEARTFAILURE.118.005853","volume":"13","author":"J Tongers","year":"2020","unstructured":"Tongers J, Sieweke J-T, K\u00fchn C, et al. Early escalation of mechanical circulatory support stabilizes and potentially rescues patients in refractory cardiogenic shock. Circ Heart Fail. 2020;13(3):e005853.","journal-title":"Circ Heart Fail"},{"issue":"1","key":"2040_CR46","first-page":"11","volume":"12","author":"K Moazzami","year":"2017","unstructured":"Moazzami K, Dolmatova EV, Cocke TP, et al. Left ventricular mechanical support with the Impella during extracorporeal membrane oxygenation. J Tehran Heart Cent. 2017;12(1):11\u20134.","journal-title":"J Tehran Heart Cent"},{"issue":"5","key":"2040_CR47","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1097\/MAT.0000000000000392","volume":"62","author":"P Schiller","year":"2016","unstructured":"Schiller P, Vikholm P, Hellgren L. Experimental venoarterial extracorporeal membrane oxygenation induces left ventricular dysfunction. ASAIO J. 2016;62(5):518\u201324.","journal-title":"ASAIO J"},{"key":"2040_CR48","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1186\/s12967-015-0634-6","volume":"13","author":"P Ostadal","year":"2015","unstructured":"Ostadal P, Mlcek M, Kruger A, et al. Increasing venoarterial extracorporeal membrane oxygenation flow negatively affects left ventricular performance in a porcine model of cardiogenic shock. J Transl Med. 2015;13:266.","journal-title":"J Transl Med"},{"issue":"6","key":"2040_CR49","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1097\/MAT.0b013e3182a4b2f6","volume":"59","author":"L Rupprecht","year":"2013","unstructured":"Rupprecht L, Fl\u00f6rchinger B, Schopka S, et al. Cardiac decompression on extracorporeal life support: a review and discussion of the literature. ASAIO J. 2013;59(6):547\u201353.","journal-title":"ASAIO J"},{"issue":"2","key":"2040_CR50","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1007\/s12265-019-9863-z","volume":"12","author":"J Curran","year":"2019","unstructured":"Curran J, Burkhoff D, Kloner RA. Beyond reperfusion: acute ventricular unloading and cardioprotection during myocardial infarction. J Cardiovasc Transl Res. 2019;12(2):95\u2013106.","journal-title":"J Cardiovasc Transl Res"},{"issue":"14","key":"2040_CR51","doi-asserted-by":"publisher","first-page":"1674","DOI":"10.1016\/j.jacc.2016.01.069","volume":"67","author":"GW Stone","year":"2016","unstructured":"Stone GW, Selker HP, Thiele H, et al. Relationship between infarct size and outcomes following primary PCI: patient-level analysis from 10 randomized trials. J Am Coll Cardiol. 2016;67(14):1674\u201383.","journal-title":"J Am Coll Cardiol"},{"issue":"Suppl 2","key":"2040_CR52","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1002\/ejhf.853","volume":"19","author":"CA den Uil","year":"2017","unstructured":"den Uil CA, Jewbali LS, Heeren MJ, Constantinescu AA, Van Mieghem NM, Reis Miranda DD. Isolated left ventricular failure is a predictor of poor outcome in patients receiving veno-arterial extracorporeal membrane oxygenation. Eur J Heart Fail. 2017;19(Suppl 2):104\u20139.","journal-title":"Eur J Heart Fail"},{"key":"2040_CR53","doi-asserted-by":"publisher","first-page":"2153","DOI":"10.1007\/s00134-018-5442-z","volume":"44","author":"P Danial","year":"2018","unstructured":"Danial P, Hajage D, Nguyen LS, et al. Percutaneous versus surgical femoro-femoral veno-arterial ECMO: a propensity score matched study. Intensive Care Med. 2018;44:2153\u201361.","journal-title":"Intensive Care Med"},{"issue":"6\u20137","key":"2040_CR54","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1016\/j.acvd.2020.02.001","volume":"113","author":"L Bonello","year":"2020","unstructured":"Bonello L, Delmas C, Gaubert M, Schurtz G, Ouattara A, Roubille F. Trials of mechanical circulatory support with percutaneous axial flow pumps in cardiogenic shock complicating acute myocardial infarction: mission impossible? Arch Cardiovasc Dis. 2020;113(6\u20137):448\u201360.","journal-title":"Arch Cardiovasc Dis"},{"issue":"1","key":"2040_CR55","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.jtcvs.2010.07.075","volume":"142","author":"Y Lamarche","year":"2011","unstructured":"Lamarche Y, Cheung A, Ignaszewski A, et al. Comparative outcomes in cardiogenic shock patients managed with Impella microaxial pump or extracorporeal life support. J Thorac Cardiovasc Surg. 2011;142(1):60\u20135.","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"4","key":"2040_CR56","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1177\/2048872618805486","volume":"8","author":"DM Ouweneel","year":"2019","unstructured":"Ouweneel DM, de Brabander J, Karami M, et al. Real-life use of left ventricular circulatory support with Impella in cardiogenic shock after acute myocardial infarction: 12 years AMC experience. Eur Heart J Acute Cardiovasc Care. 2019;8(4):338\u201349.","journal-title":"Eur Heart J Acute Cardiovasc Care"}],"container-title":["Advances in Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-022-02040-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12325-022-02040-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-022-02040-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,16]],"date-time":"2023-11-16T04:21:03Z","timestamp":1700108463000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12325-022-02040-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,23]]},"references-count":56,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,3]]}},"alternative-id":["2040"],"URL":"https:\/\/doi.org\/10.1007\/s12325-022-02040-5","relation":{},"ISSN":["0741-238X","1865-8652"],"issn-type":[{"value":"0741-238X","type":"print"},{"value":"1865-8652","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,23]]},"assertion":[{"value":"3 September 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 January 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 January 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}